Peter S. Harper
Impact in
- Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases
- Neurology top 0.2%
- Neurofibromatosis and Schwannoma Cases
- Neurological disorders and treatments
Papers in
-
- Genetic Neurodegenerative Diseases 90
- Neurology 44
- Neurological disorders and treatments 18
- Neurofibromatosis and Schwannoma Cases 16
- Co-authors
- D. A. S. CompstonSusan HusonDuncan J. ShawMeena UpadhyayaM. SarfaraziNick ThomasPeter LuntH G Harley
- Journals
- Journal of Medical Genetics (49 papers)Human Genetics (31 papers)Clinical Genetics (14 papers)Archives of Disease in Childhood (10 papers)The Lancet (9 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter S. Harper
247 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Cellular and Molecular Neuroscience 3.1k
- Neurology 2.5k
- Genetics 1.9k
- Molecular Biology 4.6k
- Genetics 641
Countries citing papers authored by Peter S. Harper
This map shows the geographic impact of Peter S. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Harper more than expected).
Fields of papers citing papers by Peter S. Harper
This network shows the impact of papers produced by Peter S. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Harper. The network helps show where Peter S. Harper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter S. Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 2 | |
| 2 | Clinical genetics in Britain: origins and development | 2010 | 12 |
| 3 | Australia's environment : issues and trends, 2006 | 2006 | 37 |
| 4 | Milo Keynes, A W F Edwards, and Robert Peel (eds), A century of Mendelism in human genetics: proceedings of a symposium organised by the Galton Institute and held at the Royal Society of Medicine | 2005 | 1 |
| 5 | Landmarks in medical Genetics :classic papers with commentaries | 2004 | 12 |
| 6 | 2002 | 37 | |
| 7 | 1999 | 19 | |
| 8 | Sequence variation at the phenylalanine hydroxylase gene in the British Isles. | 1997 | 19 |
| 9 | 1993 | 28 | |
| 10 | 1993 | 19 | |
| 11 | 1992 | 4 | |
| 12 | Reply to Goodship et al. | 1992 | 2 |
| 13 | 1989 | 4 | |
| 14 | 1988 | 3 | |
| 15 | 1988 | 5 | |
| 16 | 1986 | 26 | |
| 17 | 1985 | 2 | |
| 18 | 1983 | 2 | |
| 19 | 1983 | 44 | |
| 20 | 1975 | 2 |
About Peter S. Harper
Peter S. Harper is a scholar working on Cellular and Molecular Neuroscience, Neurology, Genetics, Genetics and Molecular Biology, having authored 251 papers that have together received 8.8k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (90 papers), Mitochondrial Function and Pathology (35 papers), Muscle Physiology and Disorders (34 papers), BRCA gene mutations in cancer (24 papers), Neurological disorders and treatments (18 papers), Neurogenetic and Muscular Disorders Research (18 papers), Neurofibromatosis and Schwannoma Cases (16 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.1k citations), Neurology (2.5k citations), Genetics (1.9k citations), Molecular Biology (4.6k citations) and Genetics (641 citations). Peter S. Harper has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include D. A. S. Compston, Susan Huson, Duncan J. Shaw, Meena Upadhyaya, M. Sarfarazi, Nick Thomas, Peter Lunt, H G Harley, Peggy Clark and William Reardon. Their work appears in journals such as Journal of Medical Genetics, Human Genetics, Clinical Genetics, Archives of Disease in Childhood and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.